Novel Paramagnetic Contrast Agents for Molecular Imaging and Targeted Drug Delivery

Author(s): Gregory M. Lanza, Patrick Winter, Shelton Caruthers, Anne Schmeider, Kathy Crowder, Anne Morawski, Huiying Zhang, Michael J. Scott, Samuel A. Wickline

Journal Name: Current Pharmaceutical Biotechnology

Volume 5 , Issue 6 , 2004

Become EABM
Become Reviewer
Call for Editor


Molecular biology and genomic sciences are revealing the early biological signatures for many diseases. In response, the Molecular Imaging community is rapidly developing contrast agents to visualize the nascent pathological changes and to concomitantly deliver treatment directly to the site of disease. The evaluation, development and use of these new agents require a complementary understanding of contrast chemistry and imaging techniques. The fundamental issues surrounding magnetic contrast agent development, rational drug delivery, MR molecular imaging, and their interdependence are elucidated.

Keywords: molecular imaging, restenosis, drug delivery, nanoparticle, nanotechnology, magnetic resonance imaging, vascular smooth muscle cells

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2004
Page: [495 - 507]
Pages: 13
DOI: 10.2174/1389201043376544
Price: $65

Article Metrics

PDF: 5